Drug Metabolism refers to the biochemical processes by which a drug is transformed within the body. This intricate process primarily occurs in the liver and involves a series of enzymatic reactions aimed at converting drugs into metabolites that can be easily excreted from the body. The primary goal of drug metabolism is to facilitate the elimination of drugs from the system while often making them more water-soluble for efficient excretion through urine or bile. The process of drug metabolism can be broadly categorized into two phases: Phase I and Phase II metabolism. Phase I metabolism typically involves oxidation, reduction, or hydrolysis reactions, mediated mainly by enzymes such as cytochrome P450 (CYP) enzymes. These reactions often introduce or expose functional groups on the drug molecule, rendering it more amenable to subsequent modification. Following Phase I metabolism, Phase II reactions involve the conjugation of the drug or its metabolites with endogenous molecules such as glucuronic acid, sulfate, or amino acids. This conjugation process enhances the water solubility of the drug metabolites, facilitating their elimination via urine or bile. Enzymes such as UDP-glucuronosyltransferases (UGTs) and sulfotransferases are pivotal in Phase II metabolism. The interplay between Phase I and Phase II metabolism ensures efficient drug elimination while often producing metabolites with altered pharmacological activity. However, it's essential to note that drug metabolism can vary significantly among individuals due to genetic factors, environmental influences, and concurrent medications.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico